Skip to main content
Fig. 3 | BMC Surgery

Fig. 3

From: Real-world efficacy of adjuvant therapy for totally resected stage I lung adenocarcinoma patients with pathological high-risk factors: propensity score analysis

Fig. 3

(A) The disease-free survival curves for totally resected stage I lung adenocarcinoma patients with pathological high-risk factors with or without adjuvant therapy after propensity score matching, p = 0.004. (B) The DFS curves for totally resected stage I lung adenocarcinoma patients with pathological high-risk factors with chemotherapy or with targeted therapy after propensity score matching, p = 0.942

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us